A METABOLIC APPROACH TO GLOBAL HEALTH TRANSFORMATION
Welcome to Terrain Holdings
Terrain Holdings brings together leading medical experts dedicated to revolutionizing cancer and chronic disease treatment through a personalized, metabolic approach. By encompassing education, technology, research, therapeutics, and accessibility, we create individualized healthcare solutions beyond standard practices, focusing on metabolic health and scientifically proven data-driven therapies.
UNVEILING THE FUTURE Of METABOLIC HEALTH
Metabolic Therapeutics
MitoVida is dedicated to developing treatments that repair mitochondrial dysfunction, addressing the fundamental cause of cancer and other diseases and helping individuals live happier, healthier and more whole lives.
Metabolic Health Data Platform
An advanced health tech platform that provides in-depth assessments of a patient's metabolic health, allowing physicians to create personalized treatment strategies. Leveraging AI and a diverse dataset from trained clinicians incorporates extensive treatment therapies and patient data, ultimately enhancing research and improving treatment outcomes.
Metabolic Education
We offer specialized educational courses for clinicians, practitioners, and individuals that focus on improving the quality and effectiveness of cancer treatment outcomes through a thorough understanding of metabolic health. To date, more than 600 clinicians, practitioners, and allied health professionals have been trained across over 40 countries.
AFFILIATED COMPANIES
UNVEILING THE FUTURE Of METABOLIC HEALTH
Metabolic Research & Laboratory
The foundational premise of the lab is to follow the Nobel Prize (1931) winning work of Otto Warburg, MD, based on research on cellular respiration and metabolism, particularly in cancer cells.
Metabolic Oncology Doctor & Influencer
At the age of 19, Dr. Nasha Winters was diagnosed with Stage 4 terminal ovarian cancer. She is now an integrative oncology specialist and the author of "The Metabolic Approach to Cancer" and "Mistletoe and the Emerging Future of Integrative Oncology."